Evidence map›Paper›PMID 41929870›Full record

ArticleJournal of anesthesia and translational medicine2024

Case report: Successful reversal of chronic kidney disease by epidural block with lidocaine.

Xiaomei Qiu, Baiqin Su, Qifang Li

Abstract readCase Reports
In one paragraph

Article in Journal of anesthesia and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Future perspective on chronic kidney disease management.Journal of anesthesia and translational medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaomei QiuDepartment of Anesthesiology, Chengdu First People's Hospital, Chengdu 610000, China.
Baiqin SuDepartment of Anesthesiology, Dongguan People's Hospital, Dongguan 523000, China.
Qifang LiDepartment of Anesthesiology and Perioperative Medicine, Clinical Research Center for Anesthesiology and Perioperative Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai 200434, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: IgA nephropathy (IgA N) is a leading cause of chronic kidney disease (CKD) and renal failure. However, none of the information regarding the pathogenesis of this disease suggests a curable time-limited event. This case demonstrates the feasibility of anesthesia technique for the reversal of IgA N. Case presentation: A 57-year-old male presented with hematuria and proteinuria. Considering the patient's clinical and kidney biopsy characteristics, the final diagnosis was IgA N. Epidural block was located at T6 and sustained via patient-controlled analgesia pump, delivering 0.8 % lidocaine in rapid bolus injections of 6 mL (with a lockout interval of 180 min) for 16 h daily. Following seven months of treatment, Blood pressure was stable and antihypertension drugs halted during the study period. Kidney function also got improved throughout the study in the patient, whether assessed by eGFR (from 56.18 mL/min (1.73 ㎡) to 72.9 mL/min (1.73 ㎡)) or serum creatinine concentration (decreased from 128.9 μmol/L to 103.2 μmol/L). The patient experienced a > 80 % reduction in proteinuria from baseline, and exhibited a complete remission of hematuria. Conclusions: In this case, epidural block with lidocaine successfully reverses the patient from stage 3 to stage 2 of CKD. These data suggest the feasibility of anesthesia technique for the treatment of IgA N.

Indexed as

Case reportChronic kidney diseaseEpidural blockIgA nephropathyReversal

Identifiers

PMID41929870
PMCPMC13001736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.